1
|
Darbari DS, Eigbire-Molen O, Ponisio MR, Milchenko MV, Rodeghier MJ, Casella JF, McKinstry RC, DeBaun MR. Progressive loss of brain volume in children with sickle cell anemia and silent cerebral infarct: A report from the silent cerebral infarct transfusion trial. Am J Hematol 2018; 93:E406-E408. [PMID: 30264867 DOI: 10.1002/ajh.25297] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/04/2018] [Revised: 09/20/2018] [Accepted: 09/24/2018] [Indexed: 11/11/2022]
Affiliation(s)
- Deepika S. Darbari
- Division of Hematology, Children's National Medical Center; Washington District of Columbia
- The George Washington University School of Medicine and Health Sciences; Washington District of Columbia
| | | | - Maria R. Ponisio
- Department of Radiology; Washington University School of Medicine; St Louis Missouri
| | - Mikhail V. Milchenko
- Department of Radiology; Washington University School of Medicine; St Louis Missouri
| | | | - James F. Casella
- Department of Pediatrics, Division of Hematology; Johns Hopkins School of Medicine; Baltimore Maryland
| | - Robert C. McKinstry
- Pediatric Radiology and Neuroradiology Sections, Washington University School of Medicine; St. Louis Missouri
| | - Michael R. DeBaun
- Department of Pediatrics, Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease; Vanderbilt University Medical Center; Nashville Tennessee
| |
Collapse
|
2
|
Badawy SM, Payne AB, Rodeghier MJ, Liem RI. Exercise capacity and clinical outcomes in adults followed in the Cooperative Study of Sickle Cell Disease (CSSCD). Eur J Haematol 2018; 101:532-541. [PMID: 29999202 DOI: 10.1111/ejh.13140] [Citation(s) in RCA: 8] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2018] [Revised: 07/08/2018] [Accepted: 07/09/2018] [Indexed: 12/23/2022]
Abstract
OBJECTIVES To determine the factors associated with exercise capacity in adults with sickle cell disease (SCD) and its relationship to hospitalizations and mortality. METHODS A total of 223 participants in the Cooperative Study of Sickle Cell Disease (CSSCD) (64% female, 70% hemoglobin SS/Sβ0 thalassemia, mean age 43.3 ± 7.5 years) underwent maximal exercise testing using a treadmill protocol with a mean duration of 11.6 ± 5.2 minutes. RESULTS Female sex (β = -3.34, 95% CI [-1.80, -4.88], P < 0.001), older age (β = -0.14, 95% CI [-0.24, -0.04], P = 0.005), higher body mass index (β = -0.23, 95% CI [-0.37, -0.10]; P = 0.001), and lower hemoglobin (β = 0.56, 95% CI [0.08, 1.04], P = 0.02) were independently associated with lower fitness, while there was a trend with abnormal pulmonary function testing (β = -1.42, 95% CI [-2.92, 0.07]; P = 0.06). Lower percent-predicted forced expiratory volume in 1 second (FEV1 ) was independently associated with lower fitness (β = 0.08, 95% CI [0.03, 0.13], P = 0.001). Genotype and hospitalization rates for pain and acute chest syndrome (ACS) prior to testing were not associated with exercise capacity. Baseline exercise capacity predicted neither future pain or ACS nor survival in our cohort. Adults with SCD tolerated maximal exercise testing. CONCLUSIONS Prospective studies are needed to further evaluate the impact of regular exercise and improved fitness on clinical outcomes and mortality in SCD.
Collapse
Affiliation(s)
- Sherif M Badawy
- Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.,Department of Pediatrics, Northwestern University Feinberg School Medicine, Chicago, Illinois
| | - Amanda B Payne
- Division of Blood Disorders, National Center on Birth Defects and Developmental Disabilities, Centers for Disease Control and Prevention, Atlanta, Georgia
| | | | - Robert I Liem
- Division of Hematology, Oncology and Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois.,Department of Pediatrics, Northwestern University Feinberg School Medicine, Chicago, Illinois
| |
Collapse
|
3
|
Jordan LC, Roberts Williams DO, Rodeghier MJ, Covert Greene BV, Ponisio MR, Casella JF, McKinstry RC, Noetzel MJ, Kirkham FJ, Meier ER, Fuh B, McNaull M, Sarnaik S, Majumdar S, McCavit TL, DeBaun MR. Children with sickle cell anemia with normal transcranial Doppler ultrasounds and without silent infarcts have a low incidence of new strokes. Am J Hematol 2018. [PMID: 29520844 DOI: 10.1002/ajh.25085] [Citation(s) in RCA: 7] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/09/2023]
Abstract
In a prospective cohort study, we tested the hypothesis that children with sickle cell anemia (SCA) with normal transcranial Doppler ultrasound (TCD) velocities and without silent cerebral infarcts (SCIs) would have a lower incidence rate of new neurological events (strokes, seizures or transient ischemic attacks) compared to children with normal TCD measurements and SCIs, not receiving regular blood transfusions. Nonrandomized participants from the silent cerebral infarct transfusion (SIT) Trial who had screening magnetic resonance imaging (MRI) of the brain and normal TCD measurements were included. Follow-up ended at the time of first neurological event (stroke, seizure or transient ischemic attack), start of regular blood transfusion, or loss to follow-up, whichever came first. The primary endpoint was a new neurological event. Of 421 participants included, 68 had suspected SCIs. Mean follow-up was 3.6 years. Incidence rates of new neurological events in nontransfused participants with normal TCD values with SCIs and without SCIs were 1.71 and 0.47 neurological events per 100 patient-years, respectively, P = .065. The absence of SCI(s) at baseline was associated with a decreased risk of a new neurological event (hazard ratio 0.231, 95% CI 0.062-0.858; P = .029). Local pediatric neurologists examined 67 of 68 participants with suspected SCIs and identified 2 with overt strokes classified as SCIs by local hematologists; subsequently one had a seizure and the other an ischemic stroke. Children with SCA, without SCIs, and normal TCD measurements have a significantly lower rate of new neurological events when compared to those with SCIs and normal TCD measurements. Pediatric neurology assessment may assist risk stratification.
Collapse
Affiliation(s)
- Lori C. Jordan
- Department of Pediatrics, Division of Pediatric NeurologyVanderbilt University Medical CenterNashville Tennessee
| | - Dionna O. Roberts Williams
- Department of Pediatrics, Division of Hematology/OncologyVanderbilt‐Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical CenterNashville Tennessee
| | | | - Brittany V. Covert Greene
- Department of Pediatrics, Division of Hematology/OncologyVanderbilt‐Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical CenterNashville Tennessee
| | - Maria R. Ponisio
- Department of RadiologyWashington University School of MedicineSt. Louis Missouri
| | - James F. Casella
- Department of Pediatrics, Division of Hematologythe Johns Hopkins University School of MedicineBaltimore Maryland
| | - Robert C. McKinstry
- Departments of Radiology and PediatricsWashington University School of MedicineSt. Louis Missouri
| | - Michael J. Noetzel
- Departments of Neurology and PediatricsWashington University School of MedicineSt Louis Missouri
| | - Fenella J. Kirkham
- Developmental NeurosciencesUniversity College London Great Ormond Street Institute of Child HealthLondon United Kingdom
| | - Emily R. Meier
- Indiana Hemophilia & Thrombosis CenterIndianapolis Indiana
| | - Beng Fuh
- Department of PediatricsHematology/Oncology, Brody School of Medicine at East Carolina UniversityGreenville North Carolina
| | - Melissa McNaull
- Department of PediatricsHematology/Oncology, University of Mississippi Medical CenterJackson Mississippi
| | - Sharada Sarnaik
- Department of Pediatrics, Division of Hematology/OncologyWayne State UniversityDetroit Michigan
| | - Suvankar Majumdar
- Center for Cancer and Blood Disorders, Children's National Medical CenterWashington DC
| | - Timothy L. McCavit
- Department of Pediatrics, Division of Hematology/OncologyCook Children's HospitalFort Worth Texas
| | - Michael R. DeBaun
- Department of Pediatrics, Division of Hematology/OncologyVanderbilt‐Meharry Center of Excellence in Sickle Cell Disease, Vanderbilt University Medical CenterNashville Tennessee
| |
Collapse
|
4
|
Fields ME, Hoyt-Drazen C, Abel R, Rodeghier MJ, Yarboi JM, Compas BE, King AA. A pilot study of parent education intervention improves early childhood development among toddlers with sickle cell disease. Pediatr Blood Cancer 2016; 63:2131-2138. [PMID: 27509845 PMCID: PMC5344022 DOI: 10.1002/pbc.26164] [Citation(s) in RCA: 22] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 04/08/2016] [Revised: 06/10/2016] [Accepted: 06/28/2016] [Indexed: 11/05/2022]
Abstract
BACKGROUND Young children with sickle cell disease (SCD) are at risk for cognitive delay. In addition to biologic risk factors associated with SCD, environmental factors contribute to cognitive dysfunction within this cohort. METHODS We completed a single-arm, prospective cohort study. Children with SCD between the ages of 3 and 36 months and their caregivers were followed between October 2010 and December 2013. The aim was to describe the role of a home visitation model, the home environment, and socioeconomic status in the development of young children with SCD. Primary outcome measures were the Bayley Scales of Infant and Toddler Development, Third Edition (BSID-III) and the Home Observation for Measurement of the Environment (HOME). We hypothesized that the home visitation model, Parents as Teachers® (PAT), would encourage positive parent-child interactions and improve cognitive outcomes. RESULTS Thirty-five participants had at least two PAT visits and BSID-III assessments. Mean scores within all five subtests of the BSID-III improved between enrollment and exit, with significant changes within cognitive (P = 0.016) and expressive language (EL) domains (P = 0.002). Multivariate modeling found the HOME score associated with the exit results of the cognitive domain. CONCLUSION We report longitudinal results of the first home visitation program within the early childhood SCD population and show significant improvement in cognitive and EL development. Additionally, home environment was a significant predictor of cognitive development. Randomized controlled trials to test the impact of interventions targeting the home environment are warranted for this vulnerable population.
Collapse
Affiliation(s)
- Melanie E. Fields
- Washington University School of Medicine, Department of Pediatrics, Division of Pediatric Hematology/Oncology, St. Louis, Missouri
| | - Catherine Hoyt-Drazen
- Washington University School of Medicine, Program in Occupational Therapy, St. Louis, Missouri
| | - Regina Abel
- Washington University School of Medicine, Program in Occupational Therapy, St. Louis, Missouri
| | | | - Janet M. Yarboi
- Vanderbilt University, Department of Psychology and Human Development
| | - Bruce E. Compas
- Vanderbilt University, Department of Psychology and Human Development
| | - Allison A. King
- Washington University School of Medicine, Department of Pediatrics, Division of Pediatric Hematology/Oncology, St. Louis, Missouri,Washington University School of Medicine, Program in Occupational Therapy, St. Louis, Missouri,Division of Public Health Sciences, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri
| |
Collapse
|
5
|
Liem RI, Onyejekwe K, Olszewski M, Nchekwube C, Zaldivar FP, Radom-Aizik S, Rodeghier MJ, Thompson AA. The acute phase inflammatory response to maximal exercise testing in children and young adults with sickle cell anaemia. Br J Haematol 2015; 171:854-61. [PMID: 26456230 DOI: 10.1111/bjh.13782] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/21/2015] [Accepted: 08/20/2015] [Indexed: 01/27/2023]
Abstract
Although individuals with sickle cell anaemia (SCA) have elevated baseline inflammation and endothelial activation, the acute phase response to maximal exercise has not been evaluated among children with SCA. We measured the acute phase response to maximal exercise testing for soluble vascular cell adhesion molecule (sVCAM) as well as interleukin 6 (IL6), total white blood cell (WBC) count, C-reactive protein (CRP) and D-dimer in a cohort of children with SCA and matched controls at baseline, immediately after, and 30, 60 and 120 min following exercise. Despite higher baseline levels of all biomarkers except CRP, the acute phase response from baseline to immediately after exercise was significantly greater in subjects versus controls for CRP (2·1 vs. 0·2 mg/l, P = 0·02) and D-dimer (160 vs. 10 μg/l, P < 0·01) only. Similar between-group trends were observed over time for all biomarkers, including sVCAM, IL6, total WBC, CRP and D-dimer. Lower fitness, defined by peak oxygen consumption (VO2 ), was independently associated with greater acute phase responses to exercise for sVCAM. Our results suggest maximal exercise may not be associated with any greater escalation of endothelial activation or inflammation in SCA and provide preliminary biomarker evidence for the safety of brief, high-intensity physical exertion in children with SCA.
Collapse
Affiliation(s)
- Robert I Liem
- Hematology, Oncology & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.,Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Kasiemobi Onyejekwe
- Hematology, Oncology & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.,Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Marie Olszewski
- Hematology, Oncology & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.,Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Chisalu Nchekwube
- Hematology, Oncology & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.,Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| | - Frank P Zaldivar
- Pediatric Exercise Research Center, University of California Irvine, Irvine, CA, USA
| | - Shlomit Radom-Aizik
- Pediatric Exercise Research Center, University of California Irvine, Irvine, CA, USA
| | | | - Alexis A Thompson
- Hematology, Oncology & Stem Cell Transplant, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.,Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, IL, USA
| |
Collapse
|
6
|
King AA, Rodeghier MJ, Panepinto JA, Strouse JJ, Casella JF, Quinn CT, Dowling MM, Sarnaik SA, Thompson AA, Woods GM, Minniti CP, Redding-Lallinger RC, Kirby-Allen M, Kirkham FJ, McKinstry R, Noetzel MJ, White DA, Kwiatkowski JK, Howard TH, Kalinyak KA, Inusa B, Rhodes MM, Heiny ME, Fuh B, Fixler JM, Gordon MO, DeBaun MR. Silent cerebral infarction, income, and grade retention among students with sickle cell anemia. Am J Hematol 2014; 89:E188-92. [PMID: 25042018 DOI: 10.1002/ajh.23805] [Citation(s) in RCA: 60] [Impact Index Per Article: 6.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/08/2014] [Revised: 07/10/2014] [Accepted: 07/11/2014] [Indexed: 11/11/2022]
Abstract
Children with sickle cell anemia have a higher-than-expected prevalence of poor educational attainment. We test two key hypotheses about educational attainment among students with sickle cell anemia, as measured by grade retention and use of special education services: (1) lower household per capita income is associated with lower educational attainment; (2) the presence of a silent cerebral infarct is associated with lower educational attainment. We conducted a multicenter, cross-sectional study of cases from 22 U.S. sites included in the Silent Infarct Transfusion Trial. During screening, parents completed a questionnaire that included sociodemographic information and details of their child's academic status. Of 835 students, 670 were evaluable; 536 had data on all covariates and were used for analysis. The students' mean age was 9.4 years (range: 5-15) with 52.2% male; 17.5% of students were retained one grade level and 18.3% received special education services. A multiple variable logistic regression model identified that lower household per capita income (odds ratio [OR] of quartile 1 = 6.36, OR of quartile 2 = 4.7, OR of quartile 3 = 3.87; P = 0.001 for linear trend), age (OR = 1.3; P < 0.001), and male gender (OR, 2.2; P = 0.001) were associated with grade retention; silent cerebral infarct (P = 0.31) and painful episodes (P = 0.60) were not. Among students with sickle cell anemia, household per capita income is associated with grade retention, whereas the presence of a silent cerebral infarct is not. Future educational interventions will need to address both the medical and socioeconomic issues that affect students with sickle cell anemia.
Collapse
Affiliation(s)
- Allison A. King
- Program in Occupational Therapy and Department of Pediatrics, Hematology/Oncology, Washington University School of Medicine; St. Louis Missouri
| | | | - Julie Ann Panepinto
- Division of Hematology/Oncology; Department of Pediatrics; Medical College of Wisconsin; Milwaukee Wisconsin
| | - John J. Strouse
- Division of Hematology/Oncology; Department of Pediatrics; Hematology/Oncology; Johns Hopkins University School of Medicine; Baltimore Maryland
| | - James F. Casella
- Division of Hematology/Oncology; Department of Pediatrics; Hematology/Oncology; Johns Hopkins University School of Medicine; Baltimore Maryland
| | - Charles T. Quinn
- Division of Hematology/Oncology; Department of Pediatrics; Cincinnati Children's Hospital Medical Center and University of Cincinnati; Cincinnati Ohio
| | - Michael M. Dowling
- Departments of Pediatrics; Neurology; and Neurotherapeutics; University of Texas Southwestern Medical School; Dallas Texas
| | - Sharada A. Sarnaik
- Division of Hematology/Oncology; Department of Pediatrics; Wayne State University; Detroit Michigan
| | - Alexis A. Thompson
- Division of Hematology/Oncology; Department of Pediatrics; Northwestern University; Chicago Illinois
| | - Gerald M. Woods
- Division of Hematology/Oncology; Department of Pediatrics; University of Missouri-Kansas City; Kansas City Missouri
| | - Caterina P. Minniti
- National Heart; Lung and Blood Institute; National Institutes of Health; Bethesda Maryland
| | - Rupa C. Redding-Lallinger
- Division of Hematology/Oncology; Department of Pediatrics; University of North Carolina at Chapel Hill; Chapel Hill North Carolina
| | | | - Fenella J. Kirkham
- Neurosciences Unit; Institute of Child Health; University College London; London United Kingdom
| | - Robert McKinstry
- Department of Radiology; Washington University School of Medicine; St. Louis Missouri
| | - Michael J. Noetzel
- Departments of Neurology and Pediatrics; Washington University School of Medicine; St. Louis Missouri
| | - Desiree A. White
- Department of Psychology; Washington University; St. Louis Missouri
| | - Janet K. Kwiatkowski
- Division of Hematology/Oncology; Department of Pediatrics; University of Pennsylvania, Children's Hospital of Philadelphia; Philadelphia Pennsylvania
| | - Thomas H. Howard
- Division of Hematology/Oncology; Department of Pediatrics; University of Alabama at Birmingham; Birmingham Alabama
| | - Karen A. Kalinyak
- Division of Hematology/Oncology; Department of Pediatrics; Cincinnati Children's Hospital Medical Center and University of Cincinnati; Cincinnati Ohio
| | - Baba Inusa
- Department of Paediatrics; Evelina Children's Hospital; St Thomas' Hospital National Health Service Trust; London United Kingdom
| | - Melissa M. Rhodes
- Division of Hematology/Oncology; Department of Pediatrics; The Ohio State University; Columbus Ohio
| | - Mark E. Heiny
- Division of Hematology/Oncology; Department of Pediatrics; Indiana University-Purdue University Indiana; Indianapolis Indiana
| | - Ben Fuh
- Division of Hematology/Oncology; Department of Pediatrics; Brody School of Medicine; Greenville North Carolina
| | - Jason M. Fixler
- Division of Hematology/Oncology; Department of Pediatrics; Sinai Hospital; Baltimore Maryland
| | - Mae O. Gordon
- Department of Ophthalmology and Visual Sciences; Biostatistics; Washington University School of Medicine; St. Louis Missouri
| | - Michael R. DeBaun
- Vanderbilt-Meharry Center of Excellence in Sickle Cell Disease; Division of Hematology/Oncology; Department of Pediatrics; Vanderbilt University; Nashville Tennessee
| |
Collapse
|
7
|
Roberts DO, Covert B, Rodeghier MJ, Parmar N, DeBaun MR, Thompson AA, Liem RI. Randomization is not associated with socio-economic and demographic factors in a multi-center clinical trial of children with sickle cell anemia. Pediatr Blood Cancer 2014; 61:1529-1535. [PMID: 24753128 PMCID: PMC4107131 DOI: 10.1002/pbc.25072] [Citation(s) in RCA: 8] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/19/2013] [Accepted: 03/25/2014] [Indexed: 11/09/2022]
Abstract
BACKGROUND Few studies have investigated factors influencing participation rates for minority children with a chronic disease in clinical trials. The Silent Cerebral Infarct Multi-Center Clinical (SIT) Trial provides an opportunity to study the impact of demographic and socio-economic factors on randomization in a clinical trial among Black children. Our primary objective was to characterize the factors associated with successful randomization of children with sickle cell disease (SCD) and silent cerebral infarct (SCI) in the SIT Trial after initial consent. PROCEDURE Differences in socio-economic and demographic variables, family history and disease-related variables were determined between eligible participants who were successfully randomized and those who were not randomized following initial consent. Head of household educational level and family income were examined separately for US versus non-US sites. RESULTS Of 1,176 children enrolled in the SIT Trial, 1,016 (86%) completed screening. Of 208 (20%) children with qualifying SCI on pre-randomization MRI, 196 (94%) were successfully randomized. There were no differences in socio-economic, demographic, or disease-related variables between children who were or were not randomized. Participants from non-US sites were more likely to be randomized (22% vs. 12%, P = 0.011); although, randomization by country was associated with neither head of household education nor family income. CONCLUSION In the SIT Trial, acceptance of random allocation was not associated with socio-economic or demographic factors. Although these factors may represent barriers for some participants, they should not bias investigators caring for children with SCD in their approach to recruitment for clinical trial participation.
Collapse
Affiliation(s)
- Dionna O. Roberts
- Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN
| | - Brittany Covert
- Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN
| | | | - Nagina Parmar
- Division of Hematology/Oncology, Hospital for Sick Children, Toronto, ON
| | - Michael R. DeBaun
- Department of Pediatrics, Division of Hematology/Oncology, Vanderbilt University School of Medicine, Nashville, TN
| | - Alexis A. Thompson
- Division of Hematology, Oncology & Stem Cell Transplant, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Department of Pediatrics, Northwestern University Feinberg School of Medicine
| | - Robert I. Liem
- Division of Hematology, Oncology & Stem Cell Transplant, Ann and Robert H. Lurie Children's Hospital of Chicago, Chicago, IL; Department of Pediatrics, Northwestern University Feinberg School of Medicine
| |
Collapse
|
8
|
Dowling MM, Noetzel MJ, Rodeghier MJ, Quinn CT, Hirtz DG, Ichord RN, Kwiatkowski JL, Roach ES, Kirkham FJ, Casella JF, DeBaun MR. Headache and migraine in children with sickle cell disease are associated with lower hemoglobin and higher pain event rates but not silent cerebral infarction. J Pediatr 2014; 164:1175-1180.e1. [PMID: 24529619 PMCID: PMC4078657 DOI: 10.1016/j.jpeds.2014.01.001] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/21/2013] [Revised: 10/31/2013] [Accepted: 01/02/2014] [Indexed: 10/25/2022]
Abstract
OBJECTIVE To identify risk factors for headache and migraine in children with sickle cell disease and test the hypothesis that either or both are independently associated with silent cerebral infarcts. STUDY DESIGN In this cross-sectional study, we evaluated the health history, laboratory values, and brain magnetic resonance imaging findings of participants with sickle cell disease (hemoglobinSS or hemoglobinSβ°-thalassemia) with no history of overt stroke or seizures. Participants characterized headache severity and quality. Migraine was defined by International Headache Society criteria modified for increased sensitivity in children. Neuroradiology and neurology committees adjudicated the presence of silent cerebral infarction by review of magnetic resonance imaging and standardized examination by pediatric neurologists. RESULTS The cohort included 872 children (51.1% males), ranging in age from 5 to 15 years (mean age, 9.1 years). Of these children, 317 (36.4%) reported recurrent headaches, and 132 (15.1%) reported migraines. In multivariable logistic regression analyses, both were associated with lower steady-state hemoglobin (P = .01 for headaches; P < .01 for migraines) and higher pain rate (P < .01 for headaches; P < .01 for migraines), defined as the number of admissions requiring opioids in the previous 3 years. The presence of silent cerebral infarction was not associated with recurrent headaches or migraines. Only 1.9% (6 of 317) of children with recurrent headaches received medication for headache prophylaxis. CONCLUSION Recurrent headaches and migraines are common and undertreated in children with sickle cell disease. Low hemoglobin levels and high pain rates are associated with recurrent headaches and migraines; whereas, silent cerebral infarction is not.
Collapse
Affiliation(s)
| | - Michael J Noetzel
- St. Louis Children’s Hospital and Washington University School of Medicine
| | | | - Charles T Quinn
- Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
| | - Deborah G Hirtz
- National Institutes of Health, National Institute of Neurological Disorders and Stroke, Bethesda, MD
| | - Rebecca N Ichord
- Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, PA
| | - Janet L Kwiatkowski
- Children’s Hospital of Philadelphia and the University of Pennsylvania School of Medicine, Philadelphia, PA
| | - E Steven Roach
- Division of Child Neurology, Ohio State College of Medicine
| | | | - James F Casella
- Department of Pediatrics, Division of Pediatric Hematology, the Johns Hopkins University School of Medicine, Baltimore, MD
| | - Michael R DeBaun
- Department of Pediatrics Vanderbilt-Meharry-Matthew Walker Center of Excellence in Sickle Cell Disease, Vanderbilt University School of Medicine, Nashville, TN.
| |
Collapse
|
9
|
King AA, Strouse JJ, Rodeghier MJ, Compas BE, Casella JF, McKinstry RC, Noetzel MJ, Quinn CT, Ichord R, Dowling MM, Miller JP, DeBaun MR. Parent education and biologic factors influence on cognition in sickle cell anemia. Am J Hematol 2014; 89:162-7. [PMID: 24123128 DOI: 10.1002/ajh.23604] [Citation(s) in RCA: 125] [Impact Index Per Article: 12.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/23/2013] [Accepted: 09/30/2013] [Indexed: 11/08/2022]
Abstract
Children with sickle cell anemia have a high prevalence of silent cerebral infarcts (SCIs) that are associated with decreased full-scale intelligence quotient (FSIQ). While the educational attainment of parents is a known strong predictor of the cognitive development of children in general, the role of parental education in sickle cell anemia along with other factors that adversely affect cognitive function (anemia, cerebral infarcts) is not known. We tested the hypothesis that both the presence of SCI and parental education would impact FSIQ in children with sickle cell anemia. A multicenter, cross-sectional study was conducted in 19 US sites of the Silent Infarct Transfusion Trial among children with sickle cell anemia, age 5-15 years. All were screened for SCIs. Participants with and without SCI were administered the Wechsler Abbreviated Scale of Intelligence. A total of 150 participants (107 with and 43 without SCIs) were included in the analysis. In a multivariable linear regression model for FSIQ, the absence of college education for the head of household was associated with a decrease of 6.2 points (P = 0.005); presence of SCI with a 5.2 point decrease (P = 0.017); each $1000 of family income per capita with a 0.33 point increase (P = 0.023); each increase of 1 year in age with a 0.96 point decrease (P = 0.023); and each 1% (absolute) decrease in hemoglobin oxygen saturation with 0.75 point decrease (P = 0.030). In conclusion, FSIQ in children with sickle cell anemia is best accounted for by a multivariate model that includes both biologic and socioenvironmental factors.
Collapse
Affiliation(s)
- Allison A. King
- Program in Occupational Therapy and Department of Pediatrics Hematology/Oncology; Washington University School of Medicine; St. Louis Missouri
| | - John J. Strouse
- Department of Pediatrics and Medicine; Division of Hematology; Johns Hopkins University School of Medicine; Baltimore Maryland
| | | | - Bruce E. Compas
- Department of Psychology and Human Development; Vanderbilt University; Nashville Tennessee
| | - James F. Casella
- Department of Pediatrics; Division of Hematology; the Johns Hopkins University School of Medicine; Baltimore Maryland
| | - Robert C. McKinstry
- Departments of Radiology and Pediatrics; Washington University School of Medicine; St. Louis Missouri
| | - Michael J. Noetzel
- Departments of Neurology and Pediatrics; Washington University School of Medicine; St Louis Missouri
| | - Charles T. Quinn
- Department of Pediatrics; Division of Hematology; Cincinnati Children's Hospital Medical Center; Cincinnati Ohio
| | - Rebecca Ichord
- Department of Neurology; Children's Hospital of Philadelphia; Philadelphia Pennsylvania
| | - Michael M. Dowling
- Department of Pediatrics; Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center at Dallas, Children's Medical Center Dallas; Dallas Texas
| | - J. Philip Miller
- Division of Biostatistics and Department of Internal Medicine; Washington University School of Medicine; St. Louis Missouri
| | - Michael R. DeBaun
- Department of Pediatrics; Division of Hematology/Oncology; Vanderbilt University; Nashville Tennessee
| |
Collapse
|
10
|
Cohen RT, Strunk RC, Field JJ, Rosen CL, Kirkham FJ, Redline S, Stocks J, Rodeghier MJ, DeBaun MR. Environmental tobacco smoke and airway obstruction in children with sickle cell anemia. Chest 2014; 144:1323-1329. [PMID: 23681054 DOI: 10.1378/chest.12-1569] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/01/2022] Open
Abstract
BACKGROUND The contribution of environmental tobacco smoke (ETS) exposure to pulmonary morbidity in children with sickle cell anemia (SCA) is poorly understood. We tested the hypothesis that children with SCA and ETS exposure would have an increased prevalence of obstructive lung disease and respiratory symptoms compared with children with SCA and no ETS exposure. METHODS Parent reports of ETS and respiratory symptom frequency were obtained for 245 children with SCA as part of a multicenter prospective cohort study. One hundred ninety-six children completed pulmonary function testing. Multivariable regression models were used to evaluate the associations between ETS exposure at different time points (prenatal, infant [birth to 2 years], preschool [2 years to first grade], and current) and lung function and respiratory symptoms. RESULTS Among the 245 participants, a high prevalence of prior (44%) and current (29%) ETS exposure was reported. Of the 196 children who completed pulmonary function testing, those with parent-reported infant and current ETS exposure were more likely to have airway obstruction (defined as an FEV1/FVC ratio below the lower limit normal) compared with unexposed children (22.0% vs 3.1%, P < .001). Those with ETS exposure also had a lower forced expiratory flow, midexpiratory phase/FVC ratio (0.82 vs 0.97, P = .001) and were more likely to have evidence of bronchodilator responsiveness (23% vs 11%, P = .03). Current and prior ETS exposure and in utero smoke exposure were associated with increased frequency of respiratory symptoms. CONCLUSIONS ETS exposure is associated with evidence of lower airway obstruction and increased respiratory symptoms in SCA.
Collapse
Affiliation(s)
- Robyn T Cohen
- Department of Pediatrics, Boston University School of Medicine, Boston, MA
| | - Robert C Strunk
- Department of Pediatrics, Washington University School of Medicine, St. Louis, MO
| | - Joshua J Field
- Blood Research Institute, Blood Center of Wisconsin, Medical College of Wisconsin, Milwaukee, WI
| | - Carol L Rosen
- Department of Pediatrics, School of Medicine, Case Western Reserve University, Cleveland, OH
| | | | - Susan Redline
- Department of Medicine, Harvard Medical School, Boston, MA
| | - Janet Stocks
- Portex Respiratory Unit, UCL Institute of Child Health, London, England
| | | | - Michael R DeBaun
- Department of Pediatrics, Vanderbilt School of Medicine, Nashville, TN.
| |
Collapse
|
11
|
Lehmann GC, Bell TR, Kirkham FJ, Gavlak JC, Ferguson TF, Strunk RC, Austin P, Rosen CL, Marshall MJ, Wilkey O, Rodeghier MJ, Warner JO, DeBaun MR. Enuresis associated with sleep disordered breathing in children with sickle cell anemia. J Urol 2012; 188:1572-6. [PMID: 22910247 DOI: 10.1016/j.juro.2012.02.021] [Citation(s) in RCA: 24] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/11/2011] [Indexed: 11/17/2022]
Abstract
PURPOSE Enuresis and sleep disordered breathing are common among children with sickle cell anemia. We evaluated whether enuresis is associated with sleep disordered breathing in children with sickle cell anemia. MATERIALS AND METHODS Baseline data were used from a multicenter prospective cohort study of 221 unselected children with sickle cell anemia. A questionnaire was used to evaluate, by parental report during the previous month, the presence of enuresis and its severity. Overnight polysomnography was used to determine the presence of sleep disordered breathing by the number of obstructive apneas and/or hypopneas per hour of sleep. Logistic and ordinal regression models were used to evaluate the association of sleep disordered breathing and enuresis. RESULTS The mean age of participants was 10.1 years (median 10.0, range 4 to 19). Enuresis occurred in 38.9% of participants and was significantly associated with an obstructive apnea-hypopnea index of 2 or more per hour after adjusting for age and gender (OR 2.19; 95% CI 1.09, 4.40; p = 0.03). Enuresis severity was associated with obstructive apneas and hypopneas with 3% or more desaturation 2 or more times per hour with and without habitual snoring (OR 3.23; 95% CI 1.53, 6.81; p = 0.001 and OR 2.07; 95% CI 1.09, 3.92; p = 0.03, respectively). CONCLUSIONS In this unselected group of children with sickle cell anemia, sleep disordered breathing was associated with enuresis. Results of this study support that children with sickle cell anemia who present with enuresis should be evaluated by a pulmonologist for sleep disordered breathing.
Collapse
Affiliation(s)
- Gloria C Lehmann
- Department of Pediatrics, Washington University School of Medicine, St. Louis, Missouri, USA
| | | | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|